2min chapter

Pharma Launch Secrets cover image

First-in-Class vs Me-Too Launch Differences and the Role of Content, Hyperpersonalization, and Technology with Frank Dolan, Founder and CEO of ARSENAL

Pharma Launch Secrets

CHAPTER

The Challenges of Launching a New Concept

Most of my experience has been a drug that is first in its class and the class is highly differentiated. When I started at Takeda back in 1999, it was a small company. There were only really 500 of us when we first began. Creating that marketplace to be receptive to this new and novel concept is critical. And how do you have stopping power with a differentiated idea that they don't recognize?

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode